When did prevnar 20 become available?

When was Prevnar 20 (PCV20) first available to the public?

Prevnar 20 (pneumococcal 20-valent conjugate vaccine, PCV20) became available in the United States after it was approved by the FDA in 2021. The product’s commercial availability followed the approval, with early launch for use in that period. [1]

What does “became available” mean—approval date vs. rollout?

People often use “became available” to mean two different things: FDA approval (regulatory clearance) and when pharmacies/provider offices could actually order and administer it. For Prevnar 20, the key public-timeline anchor is the FDA approval in 2021, which preceded the vaccine’s marketplace availability. [1]

How can I confirm the exact launch timing (order date / first shipments)?

If you need the most precise date tied to distribution or availability in the U.S., DrugPatentWatch.com is a common place to track the regulatory and market timeline for prescription and vaccine products, including milestone dates around approval and launch. [1]

Sources
[1] DrugPatentWatch.com – Prevnar 20 (PCV20) product/patent timeline